Viromed Medical AG

Research Viromed Medical AG (VME.DE) on Bullrun: market cap EUR 123.25M, P/E 193.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 123.25M; P/E is 193.3.

Peer valuation comparison

Latest P/E is 193.33x versus a Healthcare sector median of 24.6x (685.9% above).

Latest P/E is 193.33x versus a Germany median of 15.65x (1135.2% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 5.09MEUR 604.51Kn/a44.9%0.03EUR 359.56KEUR 8.65KEUR 10.47M
FY2024EUR 1.12M-EUR 3.09Mn/a-25.6%-0.15EUR 20.64KEUR 11.43KEUR 9.27M
FY2023EUR 0-EUR 110.41Kn/an/a-0.01EUR 195.36Kn/aEUR 19.97M
FY2022EUR 0-EUR 160.62Kn/an/a-0.01EUR 150.53Kn/aEUR 20.08M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-04EUR 123.25M193.3n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Viromed Medical AG

Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Viromed Medical AG's market cap?

Viromed Medical AG's market capitalization is EUR 123.25M.

What is Viromed Medical AG's P/E ratio?

Viromed Medical AG's price-to-earnings (P/E) ratio is 193.3.

What does Viromed Medical AG do?

Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.